股东应立即联系该公司，因为可能有限的时间来维护您的权利。
, /PRNewswire/ -- Halper Sadeh LLC，一家投资者权益法律事务所，正在调查以下公司是否可能违反联邦证券法和/或对股东的信托责任。
Barinthus Biotherapeutics plc (NASDAQ: BRNS) 与 Clywedog Therapeutics, Inc. 的合并。根据协议条款，Barinthus 的股东将为每一股美国存托股份或普通股获得新合并公司的一股普通股。如果您是 Barinthus 的股东， 请点击这里了解您的权利和选择 。
Fifth Third Bancorp (NASDAQ: FITB) 与 Comerica Incorporated 的合并。在拟议交易完成后，Fifth Third 的股东将拥有合并公司约 73% 的股份。如果您是 Fifth Third 的股东，请点击这里了解您的法律权利和选择。
Adverum Biotechnologies, Inc. (NASDAQ: ADVM) 出售给 Eli Lilly and Company。根据拟议交易的条款，Adverum 的股东将获得每股 3.56 美元的现金，以及一项不可转让的或有价值权利 (CVR)，持有人在达到两个特定里程碑后可获得额外的最高 8.91 美元现金。如果您是 Adverum 的股东， 请点击这里了解您的权利和选择 。
Huntington Bancshares Incorporated (NASDAQ: HBAN) 与 Cadence Bank 的合并。如果您是 Huntington 的股东，请点击这里了解您的法律权利和选择。
Halper Sadeh LLC 可能会为股东寻求增加的补偿、关于拟议交易的额外披露和信息，或代表股东寻求其他救济和利益。我们将以风险代理的方式处理此案，您无需承担我们的法律费用或支出的自付费用。
鼓励股东 免费 联系该公司以讨论他们的法律权利和选择。请致电 Daniel Sadeh 或 Zachary Halper，电话 (212) 763-0060，或发送电子邮件至 [email protected] 或 [email protected]。
Halper Sadeh LLC 代表全球受证券欺诈和公司不当行为影响的投资者。我们的律师在实施公司改革和为受欺诈投资者追回数百万美元方面发挥了重要作用。
律师广告。以往的结果并不保证类似的结果。
联系信息：
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
[email protected]
[email protected]
https://www.halpersadeh.com
来源 Halper Sadeh LLP
<img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMTE5Jk5ld3NJdGVtSWQ9TlkyOTMzOCZUcmFuc21pc3Npb25fSWQ9MjAyNTExMTkxODE4UFJfTkVXU19VU1BSX19fX19OWTI5MzM4?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMTE5Jk5ld3NJdGVtSWQ9TlkyOTMzOCZUcmFuc21pc3Npb25fSWQ9MjAyNTExMTkxODE4UFJfTkVXU19VU1BSX19fX19OWTI5MzM4"/>

BRNS

Adverum生物科技

HBAN

五三银行

Halper Sadeh LLC 是一家投资者权益法律事务所，正在调查涉及 Barinthus Biotherapeutics、五三银行、Adverum 生物科技和 Huntington Bancshares 的并购中可能违反联邦证券法和信托责任的行为。鼓励股东联系该事务所以讨论他们的权利，因为 Halper Sadeh 可能会代表他们寻求增加对价、额外披露或其他救济。该事务所以风险代理费用的方式运营，代表全球投资者处理证券欺诈和公司不当行为案件

Shareholders should contact the firm immediately as there may be limited time to enforce your rights.
<div class="lb-trans">股东应立即联系该公司，因为可能有限的时间来维护您的权利。
</div>, /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
<div class="lb-trans">, /PRNewswire/ -- Halper Sadeh LLC，一家投资者权益法律事务所，正在调查以下公司是否可能违反联邦证券法和/或对股东的信托责任。
</div>Barinthus Biotherapeutics plc (NASDAQ: BRNS)'s merger with Clywedog Therapeutics, Inc. Under the terms of the agreement, Barinthus shareholders will receive one share of common stock in the new combined company for each American Depositary Share or ordinary share owned. If you are a Barinthus shareholder, click here to learn more about your rights and options .
<div class="lb-trans">Barinthus Biotherapeutics plc (NASDAQ: BRNS) 与 Clywedog Therapeutics, Inc. 的合并。根据协议条款，Barinthus 的股东将为每一股美国存托股份或普通股获得新合并公司的一股普通股。如果您是 Barinthus 的股东， 请点击这里了解您的权利和选择 。
</div>Fifth Third Bancorp (NASDAQ: FITB)'s merger with Comerica Incorporated. Upon closing of the proposed transaction, Fifth Third shareholders will own approximately 73% of the combined company. If you are a Fifth Third shareholder, click here to learn more about your legal rights and options.
<div class="lb-trans">Fifth Third Bancorp (NASDAQ: FITB) 与 Comerica Incorporated 的合并。在拟议交易完成后，Fifth Third 的股东将拥有合并公司约 73% 的股份。如果您是 Fifth Third 的股东，请点击这里了解您的法律权利和选择。
</div>Adverum Biotechnologies, Inc. (NASDAQ: ADVM)'s sale to Eli Lilly and Company. Under the terms of the proposed transaction, Adverum shareholders will receive $3.56 per share in cash plus one non-transferrable contingent value right (CVR) entitling the holder to receive up to an additional $8.91 per CVR in cash upon the achievement of two certain milestones. If you are an Adverum shareholder, click here to learn more about your rights and options .
<div class="lb-trans">Adverum Biotechnologies, Inc. (NASDAQ: ADVM) 出售给 Eli Lilly and Company。根据拟议交易的条款，Adverum 的股东将获得每股 3.56 美元的现金，以及一项不可转让的或有价值权利 (CVR)，持有人在达到两个特定里程碑后可获得额外的最高 8.91 美元现金。如果您是 Adverum 的股东， 请点击这里了解您的权利和选择 。
</div>Huntington Bancshares Incorporated (NASDAQ: HBAN)'s merger with Cadence Bank. If you are a Huntington shareholder, click here to learn more about your legal rights and options.
<div class="lb-trans">Huntington Bancshares Incorporated (NASDAQ: HBAN) 与 Cadence Bank 的合并。如果您是 Huntington 的股东，请点击这里了解您的法律权利和选择。
</div>Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders. We would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
<div class="lb-trans">Halper Sadeh LLC 可能会为股东寻求增加的补偿、关于拟议交易的额外披露和信息，或代表股东寻求其他救济和利益。我们将以风险代理的方式处理此案，您无需承担我们的法律费用或支出的自付费用。
</div>Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected].
<div class="lb-trans">鼓励股东 免费 联系该公司以讨论他们的法律权利和选择。请致电 Daniel Sadeh 或 Zachary Halper，电话 (212) 763-0060，或发送电子邮件至 [email protected] 或 [email protected]。
</div>Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
<div class="lb-trans">Halper Sadeh LLC 代表全球受证券欺诈和公司不当行为影响的投资者。我们的律师在实施公司改革和为受欺诈投资者追回数百万美元方面发挥了重要作用。
</div>Attorney Advertising. Prior results do not guarantee a similar outcome.
<div class="lb-trans">律师广告。以往的结果并不保证类似的结果。
</div>Contact Information:
<div class="lb-trans">联系信息：
</div>Halper Sadeh LLC
<div class="lb-trans">Halper Sadeh LLC
</div>Daniel Sadeh, Esq.
<div class="lb-trans">Daniel Sadeh, Esq.
</div>Zachary Halper, Esq.
<div class="lb-trans">Zachary Halper, Esq.
</div>(212) 763-0060
<div class="lb-trans">(212) 763-0060
</div>[email protected]
<div class="lb-trans">[email protected]
</div>[email protected]
<div class="lb-trans">[email protected]
</div>https://www.halpersadeh.com
<div class="lb-trans">https://www.halpersadeh.com
</div>SOURCE Halper Sadeh LLP
<div class="lb-trans">来源 Halper Sadeh LLP
</div><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMTE5Jk5ld3NJdGVtSWQ9TlkyOTMzOCZUcmFuc21pc3Npb25fSWQ9MjAyNTExMTkxODE4UFJfTkVXU19VU1BSX19fX19OWTI5MzM4" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=NY29338&amp;Transmission_Id=202511191818PR_NEWS_USPR_____NY29338&amp;DateId=20251119"/>

Halper Sadeh LLC 鼓励 Barinthus Biotherapeutics、五三银行、Adverum 生物科技、Huntington Bancshares 的股东联系该公司以讨论他们的权利